北方長龍(301357.SZ):預計2024年虧損1050萬元–1550萬元
格隆匯1月24日丨北方長龍(301357.SZ)公佈,預計2024年營業收入(扣除後)11,000萬元-12,500萬元,虧損1,050萬元–1,550萬元,扣非虧損1,500萬元–2,150萬元。(一)報吿期內,受客户需求變化以及計劃執行進度等因素影響,公司主要產品軍用車輛人機環系統內飾驗收交付減少,導致公司2024年該類產品收入下降。(二)報吿期內,信用減值損失較上年同期大幅增加,主要系受客户結算進度影響,導致客户回款不及時,根據企業會計政策,計提的信用減值損失較上年有較大幅度增加。(三)報吿期內,公司收到的與政府補助相關的其他收益較上年同期下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.